Related Experiment Video
Updated: Jul 25, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Experience with a screening program for gestational diabetes]
H E Tamez Pérez1, M Rodríguez Ayala, M Treviño Hernández
1División de medicina interna y clínica de diabetes, Clínica Nova de Monterrey, N.L.
Summary
Gestational diabetes (GD) affects 6% of pregnant women in northeastern Mexico, a higher prevalence than previously reported. This condition is linked to increased rates of cesarean births and macrosomy, necessitating early intervention.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes (GD) is a significant concern during pregnancy.
- Understanding GD prevalence is crucial for maternal and infant health outcomes.
- Limited data exists on GD prevalence in specific regions like northeastern Mexico.
Purpose of the Study:
- To determine the prevalence of gestational diabetes (GD) in an outpatient clinic in northeastern Mexico.
- To compare GD prevalence with existing national data.
- To identify potential complications associated with GD.
Main Methods:
- A cohort of 732 pregnant women undergoing prenatal care was studied over two years.
- A 100g oral glucose tolerance test (OGTT) was administered with blood sampling at 1, 2, and 3 hours.
- Women were classified using American Diabetes Association criteria: normal, abnormal, or a single abnormal value.
Main Results:
- The prevalence of GD was 6% (44/732), with an additional 1.4% (10/732) showing a single abnormal OGTT value.
- Women with GD had significantly higher rates of cesarean births (43% vs. 30%) and macrosomy (25% vs. 7%) compared to women with normal OGTT.
- The group with one abnormal value showed elevated rates of cesarean births (50%) and macrosomy (10%), though not statistically significant.
Conclusions:
- The prevalence of GD in this northeastern Mexico cohort (6%) is higher than the reported national average (3.9%).
- The increased incidence of cesarean births and macrosomy in women with GD highlights the need for timely therapeutic interventions.
- Further research is warranted to explore the implications of single abnormal glucose tolerance test values.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...